Medicus Pharma (MDCX) Shares Outstanding (2023 - 2026)
Medicus Pharma's (MDCX) quarterly Shares Outstanding (Entity) came in at $17.3 million in Q4 2025, up 79.68% YoY from $9.6 million in Q4 2024, and down 17.58% on a QoQ basis from $21.0 million in Q3 2025.
Medicus Pharma (MDCX) Shares Outstanding (2023 - 2026) Analysis & Trends
Medicus Pharma (MDCX) has 3 years of Shares Outstanding (Entity) data on file, last reported at $17.3 million in Q4 2025.
- Quarterly Shares Outstanding (Entity) rose 79.68% year-over-year to $17.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $17.3 million (up 79.68% YoY) and the FY2025 annual result came in at $17.3 million, up 79.68% from the prior year.
- Shares Outstanding (Entity) retreated to $17.3 million in Q4 2025, from $21.0 million in the prior quarter.
- In the past five years, Shares Outstanding (Entity) ranged from a high of $21.0 million in Q3 2025 to a low of $3.5 million in Q4 2023.
- A 3-year average of $12.0 million and a median of $10.8 million in 2024 frame the typical range for Shares Outstanding (Entity).
- Annual changes were most pronounced in 2024 — Shares Outstanding (Entity) jumped 176.45% — and 2025, when it surged 66.13%.
- Tracing MDCX's Shares Outstanding (Entity) over 3 years: stood at $3.5 million in 2023, then jumped by 176.45% to $9.6 million in 2024, then surged by 79.68% to $17.3 million in 2025.
- The last three Shares Outstanding (Entity) figures came in at $17.3 million (Q4 2025), $21.0 million (Q3 2025), and $15.9 million (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 1.91 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 1.55 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 540.00 Mn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | 2.03 Bn |
| 10 | Medicus Pharma | 14.88 Mn | -298,205.43 | - | 55.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.28 Mn |
| Dec 31, 2025 | 17.28 Mn |
| Sep 30, 2025 | 18.63 Mn |
| Jun 30, 2025 | 14.28 Mn |
| Mar 31, 2025 | 12.24 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 9.51 Mn |
| Jun 30, 2024 | 8.17 Mn |
| Mar 31, 2024 | 8.08 Mn |
| Dec 31, 2023 | 3.48 Mn |